Сахарный диабет и климакс: современные возможности заместительной гормональной терапии
Л. В. Аккер, О. В. Стефановская, Nina Leonova et al. · Медицинский вестник Башкортостана · 2008
Research by which purpose is executed was to define{determine} influence of the drospirenon which is a part of a preparation the Angeliq, on a metabolism of carbohydrates and a condition of a hemostasis at patients with a diabetes 2 types in a postmenopause. 50 patients with the climacteric syndrome, being in the natural menopause, duration more than 2th years, 2 types suffering by a diabetes are investigated{researched}. To 30 women who are not having contra-indications the Angeliq is appointed{nominated} a preparation. Parameters of a carbohydrate exchange on a level of glucose on an empty stomach, With-пептида, insulin, an index of an insulin-resistance were estimated{appreciated}. Parameters of a hemostasis on a level thrombocyte, clotting factor, D-Dimerу initially, through 3 and 6 months of treatment. During treatment by a preparation the Angeliq we have noted authentic decrease{reduction} in a level of glucose and an insulinresistance by 6 month of reception Absence of influence on a condition system of a hemostasis. Obtained data allow to recommend a preparation the Angeliq for replaceable hormonal therapy at patients in a postmenopause, suffering diabetes 2 types as effective, safe and possessing a number{line} of additional positive properties.
Cited by 0 works.